{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:22:28Z","timestamp":1783653748011,"version":"3.55.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Neurocutaneous syndromes are a group of genetic disorders involving the nervous and cutaneous systems, including Tuberous Sclerosis Complex (TSC), neurofibromatosis type 1 (NF1), and Sturge\u2013Weber syndrome (SWS), and others. The incidence of epilepsy, a core clinical manifestation, is significantly higher than in the general population. The purpose of this narrative review is to provide an updated overview of the genetic mechanisms and recent advances in precise treatment for neurocutaneous syndrome-related epilepsy. We conducted a comprehensive search of the PubMed, Scopus, EMBASE, and Web of Science databases using all MeSH terms related to \u2018Neurocutaneous Syndromes\u2019, \u2018Epilepsy\/genetics\u2019, \u2018Signal Transduction\u2019, and \u2018Precision Medicine\u2019. Selected papers underwent review and risk of bias (RoB) assessment to evaluate core questions. Somatic or germline mutations dysregulate key signaling pathways (e.g., mTOR, Ras-MAPK, PI3K-AKT), inducing malformations of cortical development (MCD) and neuronal-glial dysfunction that collectively form epileptogenic networks. This constitutes the primary pathogenic mechanism underlying neurocutaneous syndrome-related epilepsy. Precise treatment strategies based on molecular mechanisms have achieved breakthroughs: mTOR inhibitors significantly reduce seizure frequency in TSC patients, and cannabidiol (CBD) demonstrates broad-spectrum antiepileptic efficacy in TSC and Dravet syndrome. Advances in surgical techniques, such as multimodal imaging-guided resection, improve outcomes in refractory epilepsy. However, clinical translation faces challenges including technical limitations in detecting mosaic mutations, insufficient specificity of targeted drugs, and interdisciplinary collaboration gaps. Future directions require integrating multi-omics technologies, developing novel gene therapies (e.g., CRISPR-based approaches), and establishing multicenter databases linking genotype\u2013phenotype-treatment responses to advance personalized precision medicine.<\/jats:p>","DOI":"10.3389\/fneur.2025.1642299","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:52:51Z","timestamp":1757073171000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Progress in genetic mechanisms and precise treatment of neurocutaneous syndrome-related epilepsy"],"prefix":"10.3389","volume":"16","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/WCO.0000000000000667","article-title":"The role of somatic mutational events in the pathogenesis of epilepsy","volume":"32","author":"Iffland","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1528-1167.2007.01117.x","article-title":"Epilepsy surgery in tuberous sclerosis: a systematic review","volume":"48","author":"Jansen","year":"2007","journal-title":"Epilepsia"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2012.1.FOCUS11330","article-title":"Epilepsy surgery in tuberous sclerosis: a review","volume":"32","author":"Evans","year":"2012","journal-title":"Neurosurg Focus"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e13052","DOI":"10.1111\/bpa.13052","article-title":"Variable histopathology features of neuronal dyslamination in the cerebral neocortex adjacent to epilepsy-associated vascular malformations suggest complex pathogenesis of focal cortical dysplasia ILAE type IIIc","volume":"32","author":"Miyata","year":"2022","journal-title":"Brain Pathol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0920-1211(98)00036-9","article-title":"Tuberous sclerosis-related gene expression in normal and dysplastic brain","volume":"32","author":"Vinters","year":"1998","journal-title":"Epilepsy Res"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yebeh.2011.02.010","article-title":"Pediatric epileptology","volume":"22","author":"Sahin","year":"2011","journal-title":"Epilepsy Behav"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/j.expneurol.2022.114238","article-title":"Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: a systematic review and meta-analysis","volume":"359","author":"Talwar","year":"2023","journal-title":"Exp Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1111\/epi.18325","article-title":"Cytomegalic parvalbumin neurons in fetal cases of hemimegalencephaly","volume":"66","author":"Gelot","year":"2025","journal-title":"Epilepsia"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41593-024-01634-2","article-title":"Targeting pathological cells with senolytic drugs reduces seizures in neurodevelopmental mTOR-related epilepsy","volume":"27","author":"Ribierre","year":"2024","journal-title":"Nat Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"12335","DOI":"10.1038\/s41598-023-38717-2","article-title":"Altered functional connectivity and network excitability in a model of cortical dysplasia","volume":"13","author":"Aquiles","year":"2023","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1007\/s12035-022-03033-9","article-title":"Rapamycin cannot reduce seizure susceptibility in infantile rats with malformations of cortical development lacking mTORC1 activation","volume":"59","author":"Lee","year":"2022","journal-title":"Mol Neurobiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"101691","DOI":"10.1016\/j.xcrm.2024.101691","article-title":"The complex molecular epileptogenesis landscape of glioblastoma","volume":"5","author":"Soeung","year":"2024","journal-title":"Cell Rep Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"8049","DOI":"10.1038\/s41598-025-90045-9","article-title":"Increased activation of the WNT pathway in brain tissue from patients with cortical dysplasia type IIb","volume":"15","author":"Varella","year":"2025","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"101150","DOI":"10.1016\/j.spen.2024.101150","article-title":"Genetic principles related to neurocutaneous disorders","volume":"51","author":"Ferrante","year":"2024","journal-title":"Semin Pediatr Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1101026","DOI":"10.3389\/fped.2023.1101026","article-title":"Case report: a gain-of-function of hamartin may lead to a distinct \"inverse TSC1-hamartin\" phenotype characterized by reduced cell growth","volume":"11","author":"Pratico","year":"2023","journal-title":"Front Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"100332","DOI":"10.1016\/j.clinsp.2024.100332","article-title":"Multidisciplinary team for patients with neurocutaneous syndromes: the little discussed importance of dentistry","volume":"79","author":"Tovani-Palone","year":"2024","journal-title":"Clinics (Sao Paulo)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/genes14020433","article-title":"Tuberous sclerosis, type II diabetes mellitus and the PI3K\/AKT\/mTOR signaling pathways-case report and literature review","volume":"14","author":"Jurca","year":"2023","journal-title":"Genes"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jmoldx.2023.04.003","article-title":"Detecting low-variant allele frequency mosaic pathogenic variants of NF1, TSC2, and AKT3 genes from blood in patients with neurodevelopmental disorders","volume":"25","author":"Kim","year":"2023","journal-title":"J Mol Diagn"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.annder.2022.02.007","article-title":"Dermatological and genetic data in tuberous sclerosis: a prospective single-center study of 38 patients","volume":"149","author":"Secco","year":"2022","journal-title":"Ann Dermatol Venereol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e54567","DOI":"10.7759\/cureus.54567","article-title":"Lambdoid suture defect in a 12-year-old Neurofibromatosis patient","volume":"16","author":"Almahmood","year":"2024","journal-title":"Cureus"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1002\/pro.70042","article-title":"Allosteric modulation of NF1 GAP: differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants","volume":"34","author":"Xu","year":"2025","journal-title":"Protein Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41379-022-01122-7","article-title":"Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature","volume":"35","author":"Chlopek","year":"2022","journal-title":"Mod Pathol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10456-022-09841-w","article-title":"A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis","volume":"25","author":"Galeffi","year":"2022","journal-title":"Angiogenesis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40478-024-01757-4","article-title":"MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge weber syndrome","volume":"12","author":"Nasim","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10456-024-09950-8","article-title":"Similarities and differences between brain and skin GNAQ p.R183Q driven capillary malformations","volume":"27","author":"Nasim","year":"2024","journal-title":"Angiogenesis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"iyad077","DOI":"10.1093\/genetics\/iyad077","article-title":"Developmental expression of the Sturge-weber syndrome-associated genetic mutation in Gnaq: a formal test of Happle's paradominant inheritance hypothesis","volume":"224","author":"Wetzel-Strong","year":"2023","journal-title":"Genetics"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1182\/hematology.2024000598","article-title":"Molecular landscape and classification of vascular anomalies","volume":"2024","author":"Seront","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jid.2023.08.028","article-title":"GNAQ\/GNA11 mosaicism causes aberrant calcium signaling susceptible to targeted therapeutics","volume":"144","author":"Zecchin","year":"2024","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/jcm13061648","article-title":"Neurocutaneous diseases: diagnosis, management, and treatment","volume":"13","author":"Kioutchoukova","year":"2024","journal-title":"J Clin Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.det.2022.07.002","article-title":"Genetic causes of vascular malformations and common signaling pathways involved in their formation","volume":"40","author":"Rose","year":"2022","journal-title":"Dermatol Clin"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1136\/bmjno-2023-000559","article-title":"Peculiar aetiology for orbital apex syndrome: Wyburn-Mason syndrome as orbital apex lesion","volume":"6","author":"Barros","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41380-024-02863-4","article-title":"Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta-analysis","volume":"30","author":"Payne","year":"2025","journal-title":"Mol Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/epi.18000","article-title":"Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N-methyl-D-aspartate receptors","volume":"65","author":"Pineau","year":"2024","journal-title":"Epilepsia"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"105012","DOI":"10.1016\/j.ejmg.2025.105012","article-title":"Lack of behavioural improvement with sirolimus in a patient with MTOR-related macrocephaly with pigmentary mosaicism: a new case report","volume":"75","author":"Bonniaud","year":"2025","journal-title":"Eur J Med Genet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40478-023-01532-x","article-title":"An integrated genetic analysis of epileptogenic brain malformed lesions","volume":"11","author":"Fujita","year":"2023","journal-title":"Acta Neuropathol Commun"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/neup.12875","article-title":"Somatic mosaicism of the PI3K-AKT-MTOR pathway is associated with hemimegalencephaly in fetal brains","volume":"43","author":"Itoh","year":"2023","journal-title":"Neuropathology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/epi.17332","article-title":"Precision medicine for genetic epilepsy on the horizon: recent advances, present challenges, and suggestions for continued progress","volume":"63","author":"Knowles","year":"2022","journal-title":"Epilepsia"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1080\/17460441.2023.2150164","article-title":"Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy","volume":"17","author":"Miziak","year":"2022","journal-title":"Expert Opin Drug Discov"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/MOP.0000000000001170","article-title":"Updates on the diagnostic evaluation, genotype-phenotype correlation, and treatments of genetic epilepsies","volume":"34","author":"Zimmern","year":"2022","journal-title":"Curr Opin Pediatr"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pediatrneurol.2023.08.019","article-title":"Treatment of refractory epilepsy with MEK inhibitor in patients with RASopathy","volume":"148","author":"D'Onofrio","year":"2023","journal-title":"Pediatr Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/epi4.12699","article-title":"Real-world data on cannabidiol treatment of various epilepsy subtypes: a retrospective, multicenter study","volume":"8","author":"Kuhne","year":"2023","journal-title":"Epilepsia Open"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/NRR.NRR-D-24-00877","article-title":"Investigation of epilepsy-related genes in a Drosophila model","volume":"21","author":"Qu","year":"2026","journal-title":"Neural Regen Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13256-025-05137-x","article-title":"Triple pathology in a patient with uncontrolled epilepsy: a case report","volume":"19","author":"Ranji","year":"2025","journal-title":"J Med Case Rep"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.25259\/JNRP_510_2023","article-title":"The profile of epilepsy and its characteristics in children with neurocutaneous syndromes","volume":"15","author":"Saini","year":"2024","journal-title":"J Neurosci Rural Pract"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5414\/CN111425","article-title":"Renal involvement in genetic neurocutaneous syndromes","volume":"102","author":"Izzedine","year":"2024","journal-title":"Clin Nephrol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.33588\/rn.7906.2024086","article-title":"Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian epilepsy society of the new drugs cenobamate, fenfluramine and cannabidiol","volume":"79","author":"Arenas-Cabrera","year":"2024","journal-title":"Rev Neurol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S2352-4642(24)00196-2","article-title":"The expanding field of genetic developmental and epileptic encephalopathies: current understanding and future perspectives","volume":"8","author":"Specchio","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"106074","DOI":"10.1016\/j.nbd.2023.106074","article-title":"RAS pathway: the new frontier of brain mosaicism in epilepsy","volume":"180","author":"Sran","year":"2023","journal-title":"Neurobiol Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42238-023-00186-9","article-title":"The therapeutic potential of purified cannabidiol","volume":"5","author":"O'Sullivan","year":"2023","journal-title":"J Cannabis Res"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1089\/can.2022.0255","article-title":"Cannabidiol add-on in glycosylphosphatidylinositol-related drug-resistant epilepsy","volume":"9","author":"Riva","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/cpt.2408","article-title":"Pharmacogenetic predictors of Cannabidiol response and tolerability in treatment-resistant epilepsy","volume":"110","author":"Davis","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3390\/molecules29091981","article-title":"CBD in the treatment of epilepsy","volume":"29","author":"Borowicz-Reutt","year":"2024","journal-title":"Molecules"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neurol.2023.07.012","article-title":"High-purified cannabidiol efficacy and safety in a cohort of adult patients with various types of drug-resistant epilepsies","volume":"180","author":"Perriguey","year":"2024","journal-title":"Rev Neurol (Paris)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1124\/dmd.123.001435","article-title":"Advances and challenges in modeling Cannabidiol pharmacokinetics and hepatotoxicity","volume":"52","author":"Beers","year":"2024","journal-title":"Drug Metab Dispos"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/cpt.3004","article-title":"Assessing liver effects of Cannabidiol and valproate alone and in combination using quantitative systems toxicology","volume":"114","author":"Lakhani","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1590\/1806-9282.2022D689","article-title":"Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex","volume":"68","author":"Silvinato","year":"2022","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41573-024-00981-w","article-title":"New epilepsy therapies in development","volume":"23","author":"Klein","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"915004","DOI":"10.3389\/fphar.2022.915004","article-title":"On-line solid phase extraction high performance liquid chromatography method coupled with tandem mass spectrometry for the therapeutic monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in human serum and saliva","volume":"13","author":"Franco","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"829116","DOI":"10.3389\/fneur.2022.829116","article-title":"A review of targeted therapies for monogenic epilepsy syndromes","volume":"13","author":"Zimmern","year":"2022","journal-title":"Front Neurol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s13311-020-00835-4","article-title":"From genetic testing to precision medicine in epilepsy","volume":"17","author":"Striano","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"107961","DOI":"10.1016\/j.yebeh.2021.107961","article-title":"New paradigms for the treatment of pediatric monogenic epilepsies: progressing toward precision medicine","volume":"131","author":"Specchio","year":"2022","journal-title":"Epilepsy Behav"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/dmcn.14929","article-title":"Precision therapy in the genetic epilepsies of childhood","volume":"63","author":"Byrne","year":"2021","journal-title":"Dev Med Child Neurol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1534913","DOI":"10.3389\/fneur.2025.1534913","article-title":"Innovative epilepsy management: a combined figure of EEG categorization and medication mechanisms","volume":"16","author":"Taha","year":"2025","journal-title":"Front Neurol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"805007","DOI":"10.3389\/fneur.2022.805007","article-title":"Gene therapy: novel approaches to targeting monogenic epilepsies","volume":"13","author":"Goodspeed","year":"2022","journal-title":"Front Neurol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ajmg.c.32022","article-title":"Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: clinical presentation and associations with genotype","volume":"190","author":"Kenney-Jung","year":"2022","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41591-024-02924-9","article-title":"The fasciola cinereum of the hippocampal tail as an interventional target in epilepsy","volume":"30","author":"Jamiolkowski","year":"2024","journal-title":"Nat Med"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41573-024-01086-0","article-title":"Chemical engineering of CRISPR-Cas systems for therapeutic application","volume":"24","author":"Barber","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40291-023-00687-6","article-title":"Viral vector-based gene therapy for epilepsy: what does the future hold?","volume":"28","author":"Bettegazzi","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s12519-024-00843-w","article-title":"Recent advances and current status of gene therapy for epilepsy","volume":"20","author":"Cai","year":"2024","journal-title":"World J Pediatr"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3390\/jcm13185647","article-title":"Placental gene therapy for fetal growth restriction and preeclampsia: preclinical studies and prospects for clinical application","volume":"13","author":"Majumder","year":"2024","journal-title":"J Clin Med"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"C1384","DOI":"10.1152\/ajpcell.00470.2024","article-title":"Homeostatic regulation of brain activity: from endogenous mechanisms to homeostatic nanomachines","volume":"327","author":"Michetti","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/ijms241411347","article-title":"Drug-inducible gene therapy effectively reduces spontaneous seizures in kindled rats but creates off-target side effects in inhibitory neurons","volume":"24","author":"Sullivan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s13311-021-01123-5","article-title":"Clinical trial Design for Disease-Modifying Therapies for genetic epilepsies","volume":"18","author":"Brock","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1055\/a-1995-5405","article-title":"Gene therapy for epilepsy: clinical studies are on the road","volume":"91","author":"Muller","year":"2023","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s13311-021-01137-z","article-title":"Haploinsufficiency, dominant negative, and gain-of-function mechanisms in epilepsy: matching therapeutic approach to the pathophysiology","volume":"18","author":"Carvill","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/ICU.0000000000000712","article-title":"Retinal manifestations of the neurocutaneous disorders","volume":"31","author":"Engelhard","year":"2020","journal-title":"Curr Opin Ophthalmol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/ane.13446","article-title":"Valproic acid use in fertile women with genetic generalized epilepsies","volume":"144","author":"Steinbart","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"891621","DOI":"10.3389\/fnmol.2022.891621","article-title":"Imaging genetics in epilepsy: current knowledge and new perspectives","volume":"15","author":"Wang","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"110380","DOI":"10.1016\/j.yebeh.2025.110380","article-title":"Cognitive and neuro-psychiatric profile in adult patients with epilepsy secondary to tuberous sclerosis complex","volume":"166","author":"Toscano-Prat","year":"2025","journal-title":"Epilepsy Behav"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"109139","DOI":"10.1016\/j.yebeh.2023.109139","article-title":"Novel GATOR1 variants in focal epilepsy","volume":"141","author":"Kovacevic","year":"2023","journal-title":"Epilepsy Behav"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/epd2.20254","article-title":"A retrospective study of the yield of next-generation sequencing in the diagnosis of developmental and epileptic encephalopathies and epileptic encephalopathies in 0-12 years aged children at a single tertiary care hospital in South India","volume":"26","author":"Murthy","year":"2024","journal-title":"Epileptic Disord"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"149120","DOI":"10.1016\/j.brainres.2024.149120","article-title":"Unraveling the genetic basis of epilepsy: recent advances and implications for diagnosis and treatment","volume":"1843","author":"Dwivedi","year":"2024","journal-title":"Brain Res"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.wneu.2020.03.031","article-title":"Innovations in the neurosurgical Management of Epilepsy","volume":"139","author":"Hoffman","year":"2020","journal-title":"World Neurosurg"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s13311-021-01110-w","article-title":"Rational small molecule treatment for genetic epilepsies","volume":"18","author":"Goldberg","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/epi.18209","article-title":"The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: new mechanism-based therapeutic options","volume":"66","author":"Specchio","year":"2025","journal-title":"Epilepsia"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1080\/14656566.2022.2055461","article-title":"A review of the pharmacotherapeutic considerations for managing epilepsy in people with autism","volume":"23","author":"Watkins","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurol.2022.12.007","article-title":"mTOR-therapy and targeted treatment opportunities in mTOR-related epilepsies associated with cortical malformations","volume":"179","author":"Auvin","year":"2023","journal-title":"Rev Neurol (Paris)"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"137881","DOI":"10.1016\/j.neulet.2024.137881","article-title":"Loss of Slc35a2 alters development of the mouse cerebral cortex","volume":"836","author":"Elziny","year":"2024","journal-title":"Neurosci Lett"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.pneurobio.2023.102480","article-title":"Multi-omics integration and epilepsy: towards a better understanding of biological mechanisms","volume":"227","author":"Chong","year":"2023","journal-title":"Prog Neurobiol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1016\/j.ebr.2021.100477","article-title":"Genetic cause of epilepsy in a Greek cohort of children and young adults with heterogeneous epilepsy syndromes","volume":"16","author":"Zaganas","year":"2021","journal-title":"Epilepsy Behav Rep"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1642299\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:52:52Z","timestamp":1757073172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1642299\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":90,"alternative-id":["10.3389\/fneur.2025.1642299"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1642299","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1642299"}}